ClassID:

96137

C07F9/65061 - CPC Classification

Classification description:

Recent Application in this class:
#1
20180280416
2018-10-04

Dosage forms for oral administration of zoledronic acid or related compounds for treating disease

#2
20180222869
2018-08-09

ANTICANCER DRUGS INCLUDING THE CHEMICAL STRUCTURES OF AN ANDROGEN RECEPTOR LIGAND AND A HISTONE DEACETYLASE INHIBITOR

#3
20180194736
2018-07-12

Hydantoin containing deoxyuridine triphosphatase inhibitors

#4
20180153833
2018-06-07

Treatment and diagnosis of melanoma

#5
20180064829
2018-03-08

FLUORESCENT BISPHOSPHONATE ANALOGS

#6
20180022769
2018-01-25

Fluorine-containing bisphosphonic acid derivative and use thereof

#7
20180015112
2018-01-18

Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome

#8
20170319525
2017-11-09

Treatment and diagnosis of melanoma

#9
20170260144
2017-09-14

Methods for the safe administration of imidazole or imidazolium compounds

#10
20170252361
2017-09-07

Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome

#11
20170217903
2017-08-03

Anticancer drugs including the chemical structures of an androgen receptor ligand and a histone deacetylase inhibitor

#12
20170087169
2017-03-30

Compositions for administration of zoledronic acid or related compounds for treating lower back pain

#13
20170056426
2017-03-02

Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome

#14
20170022227
2017-01-26

Crystallization method and bioavailability

#15
20170022226
2017-01-26

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

#16
20170022225
2017-01-26

NOVEL CRYSTALLINE FORMS

#17
20160331726
2016-11-17

Treatment and diagnosis of melanoma

#18
20160331679
2016-11-17

Methods for the safe administration of imidazole or imidazolium compounds

#19
20160271600
2016-09-22

Ligand compound, catalyst system for olefin oligomerization, and olefin oligomerization method using the same

#20
20160095872
2016-04-07

Therapeutic compositions comprising imidazole and imidazolium compounds

#21
20160024241
2016-01-28

Polymer nanoparticles

#22
20160016982
2016-01-21

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

#23
20160016979
2016-01-21

Process for manufacture of gadofosveset trisodium monohydrate

#24
20150306116
2015-10-29

Oral forms of a phosphonic acid derivative

#25
20150225431
2015-08-13

Method for the synthesis of aminoalkylenephosphonic acid

#26
20150157564
2015-06-11

Methods for the safe administration of imidazole or imidazolium compounds

#27
20150137666
2015-05-21

Reactive ionic liquid, and ion-immobilized metal oxide particle, ion-immobilized elastomer, and transducer using same

#28
20150073053
2015-03-12

Treatment of drug resistant cancer

#29
20150023955
2015-01-22

Treatment and diagnosis of melanoma

#30
20150005258
2015-01-01

Modified creatine compounds

#31
20140316533
2014-10-23

Endosseous implant

#32
20140107076
2014-04-17

Crystallization method and bioavailability

#33
20140057875
2014-02-27

Crystallization method and bioavailability

#34
20140057796
2014-02-27

Method for the diagnosis, prognosis and treatment of breast cancer metastasis

#35
20140018321
2014-01-16

Imidazole prodrug LXR modulators

#36
20130316982
2013-11-28

Crystalline forms

#37
20130281687
2013-10-24

Methods of preparing substituted nucleotide analogs

#38
20130264554
2013-10-10

Organic electroluminescent device

#39
20130253181
2013-09-26

Methods of preparing substituted nucleotide analogs

#40
20130203829
2013-08-08

Mitochondria-targeted inhibitors of cytochrome c peroxidase for protection from apoptosis

#41
20130035315
2013-02-07

Crystallization method and bioavailability

#42
20120190647
2012-07-26

Oral forms of a phosphonic acid derivative

#43
20120115963
2012-05-10

Polymer nanoparticles

#44
20100197931
2010-08-05

Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it

#45
14481097
2015-02-24

Therapeutic compositions comprising imidazole and imidazolium compounds